Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Plos One|March 31, 2016
Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore FormationShuji Matsuoka, Yasuyuki Ishii, Atsuhito Nakao, et al.
Molecular Therapy. Methods & Clinical Development|July 21, 2025
Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancerKouta Niizuma, Toshinobu Nishimura, Jonathan Villanueva, et al.
Cell Reports|September 5, 2025
A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesisAsiri Ediriwickrema, Yusuke Nakauchi, Amy C Fan, et al.
Cancer Discovery|November 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal VulnerabilityDaniel Thomas, Manhong Wu, Yusuke Nakauchi, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
A single cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesisAsiri Ediriwickrema, Yusuke Nakauchi, Amy C Fan, et al.
Nature Biotechnology|April 8, 2024
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectorsFabian P Suchy, Daiki Karigane, Yusuke Nakauchi, et al.
Stem Cell Reports|September 1, 2015
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell TherapyMiki Ando, Toshinobu Nishimura, Satoshi Yamazaki, et al.
Leukemia|May 9, 2024
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AMLEce Canan Sayitoglu, Bogdan A Luca, Allison Paige Boss, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AMLEce Canan Sayitoglu, Bogdan A Luca, Allison P Boss, et al.
Molecular Therapy. Methods & Clinical Development|March 25, 2025
Highly efficient <i>in vivo</i> hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virusCarsten T Charlesworth, Shota Homma, Anais K Amaya, et al.
Pageof 3